Cannabis can decrease risk of digestive disorders in those with schizophrenia
A new Danish research study, recently published in the Psychological Medicine journal, found that cannabis can reduce the risk of digestive disorders and inflammatory bowel disease (IBD) among individuals diagnosed with schizophrenia.
The researchers found that patients with schizophrenia were more likely to develop digestive organ disorders, including IBD and gut-brain interaction disorders like irritable bowel syndrome (IBS) and dyspepsia. However, patients who were diagnosed with cannabis use disorder (CUD) were actually less likely to develop these disorders than patients who did not use cannabis regularly. The study reports that 23 percent of patients with schizophrenia were at risk for developing gut-brain interaction disorders or IBD by age 60. But among patients diagnosed with schizophrenia and CUD, that risk decreased to 17.8 percent. In the healthy population, only 14 percent were at risk of developing these disorders. The risk of developing IBD was found to be 3.4 percent for schizophrenia patients and 2.9 percent for the general population, but only 2.4 percent for patients with schizophrenia and CUD.
Original Article (Merry Jane):
Cannabis can decrease risk of digestive disorders in those with schizophrenia
Artwork Fair Use: Pete S from Coventry, United Kingdom